• Explore /
  • Poster
  • / Bladder-sparing treatment for muscle-invasive bladder carcinoma: A single-center, single-arm clinical study of sequential neoadjuvant chemotherapy followed by tislelizumab neoadjuvant immunotherapy.

Bladder-sparing treatment for muscle-invasive bladder carcinoma: A single-center, single-arm clinical study of sequential neoadjuvant chemotherapy followed by tislelizumab neoadjuvant immunotherapy.

Abstract Poster

Authors

Yu Zeng, Sr

Yu Zeng

The Cancer Hospital of Dalian University of Technology & Liaoning Cancer Hospital, Shenyang, China

Yu Zeng , Changqi Li , Chengcheng Lv , Cheng Fu , Ang Chen , Shui Fu , Huan Bi , Guangyi Shan , Yiding Wang , Zhe Wang , Qiang Liu , Bo Shao

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Urothelial Carcinoma

Track

Urothelial Carcinoma

Sub Track

Therapeutics

Clinical Trial Registration Number

ChiCTR2100050763

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 596)

DOI

10.1200/JCO.2024.42.4_suppl.596

Abstract #

596

Poster Bd #

G2

Abstract Disclosures

Similar Posters

First Author: Christopher J. Hoimes

Poster

2023 ASCO Genitourinary Cancers Symposium

Radical radiotherapy for muscle-invasive bladder cancer: A single centre experience.

Radical radiotherapy for muscle-invasive bladder cancer: A single centre experience.

First Author: Mayumi Forster

First Author: Joohyun Hong

First Author: Yali Shen